Next, to investigate whether AVEN, DAZAP2, and DNAJB1 could serve as potential prognostic biomarkers in GC patients by receiver operating characteristic (ROC) curves, the results showed that the AUC values of the three molecules were 0.559, 0.799, and 0.669, respectively, showing a predictive value for clinical prognosis of GC patients (Figure 6C). This evidence concerns the gene AVEN and gastric cancer.